Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02129218 · ClinicalTrials.gov registry record · NA
Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02129218 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 18 participants.
The verdict
NCT02129218, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This pilot clinical trial studies the feasibility of a low glycemic load diet in patients with stage I-III colon cancer. A low glycemic load diet includes foods that have low scores on the glycemic index. The glycemic index is a scale that measures how much a certain carbohydrate causes a person's blood sugar to rise. A low glycemic load diet may help decrease the chance of cancer coming back and improve the survival in patients with colon cancer.
Interventions
- OTHER laboratory biomarker analysis
- OTHER questionnaire administration
- BEHAVIORAL Standard Dietary Intervention
- BEHAVIORAL Intensified Dietary Intervention
- BEHAVIORAL Low glycemic load
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-02-16 |
| Est. Completion | 2018-07-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02129218
The ClinicalTrials.gov registry entry for NCT02129218 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT02129218 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02129218 about?
NCT02129218 is a clinical study titled "Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer". This pilot clinical trial studies the feasibility of a low glycemic load diet in patients with stage I-III colon cancer. A low glycemic load diet includes foods that have low scores on the glycemic index. The glycemic index is a scale that measures how much a certain carbohydrate causes a person's b...
What is the current status of trial NCT02129218?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2015-02-16. Estimated completion is 2018-07-10.
What interventions are being tested in trial NCT02129218?
The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER), Standard Dietary Intervention (BEHAVIORAL), Intensified Dietary Intervention (BEHAVIORAL), Low glycemic load (BEHAVIORAL).
Who is sponsoring clinical trial NCT02129218?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.